Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts
- PMID: 12577299
- DOI: 10.1002/jcb.10436
Inflammatory T cells rapidly induce differentiation of human bone marrow stromal cells into mature osteoblasts
Abstract
Activated T cells secrete multiple osteoclastogenic cytokines which play a major role in the bone destruction associated with rheumatoid arthritis. While the role of T cells in osteoclastogenesis has received much attention recently, the effect of T cells on osteoblast formation and activity is poorly defined. In this study, we investigated the hypothesis that in chronic inflammation activated T cells contribute to enhanced bone turnover by promoting osteoblastic differentiation. We show that T cells produce soluble factors that induce alkaline phosphatase activity in bone marrow stromal cells and elevated expression of mRNA for Runx2 and osteocalcin. This data indicate that T cell derived factors have the capacity to stimulate the differentiation of bone marrow stromal cells into the osteoblast phenotype. RANKL mRNA was undetectable under any conditions in highly purified bone marrow stromal cells. In contrast, RANKL was constitutively expressed in primary osteoblasts and only moderately up-regulated by activated T cell conditioned medium. Interestingly, both bone marrow stromal cells and osteoblasts expressed mRNA for RANK, which was strongly up-regulated in both cell types by activated T cell conditioned medium. Although, mRNA for the RANKL decoy receptor, osteoprotegerin, was also up-regulated by activated T cell conditioned medium, it's inhibitory effects may be mitigated by a simultaneous rise in the osteoprotegerin competitor TNF-related apoptosis-inducing ligand. Based on our data we propose that during chronic inflammation, T cells regulate bone loss by a dual mechanism involving both direct stimulation of osteoclastogenesis, by production of osteoclastogenic cytokines, and indirectly by induction of osteoblast differentiation and up-regulation of bone turnover via coupling.
Copyright 2003 Wiley-Liss, Inc.
Similar articles
-
Osteoprotegerin is a soluble decoy receptor for tumor necrosis factor-related apoptosis-inducing ligand/Apo2 ligand and can function as a paracrine survival factor for human myeloma cells.Cancer Res. 2003 Mar 1;63(5):912-6. Cancer Res. 2003. PMID: 12615702
-
Human bone marrow stromal cells protect prostate cancer cells from TRAIL-induced apoptosis.J Bone Miner Res. 2004 Oct;19(10):1712-21. doi: 10.1359/JBMR.040703. Epub 2004 Jul 7. J Bone Miner Res. 2004. PMID: 15355567
-
Alpha-lipoic acid suppresses osteoclastogenesis despite increasing the receptor activator of nuclear factor kappaB ligand/osteoprotegerin ratio in human bone marrow stromal cells.J Endocrinol. 2005 Jun;185(3):401-13. doi: 10.1677/joe.1.05995. J Endocrinol. 2005. PMID: 15930166
-
Osteoprotegerin and inflammation.Eur Cytokine Netw. 2002 Apr-Jun;13(2):144-53. Eur Cytokine Netw. 2002. PMID: 12101070 Review.
-
Update on the pathogenesis of osteolysis in multiple myeloma patients.Acta Biomed. 2004 Dec;75(3):143-52. Acta Biomed. 2004. PMID: 15796087 Review.
Cited by
-
Advances on T cell immunity in bone remodeling and bone regeneration.Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024 Aug 25;53(4):450-459. doi: 10.3724/zdxbyxb-2023-0619. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 39183057 Free PMC article. Review. Chinese, English.
-
IRE1α pathway: A potential bone metabolism mediator.Cell Prolif. 2024 Oct;57(10):e13654. doi: 10.1111/cpr.13654. Epub 2024 May 12. Cell Prolif. 2024. PMID: 38736291 Free PMC article. Review.
-
CD4+ and CD8+ T cells reduce inflammation and promote bone healing in response to titanium implants.Acta Biomater. 2024 Apr 15;179:385-397. doi: 10.1016/j.actbio.2024.03.022. Epub 2024 Mar 29. Acta Biomater. 2024. PMID: 38554889
-
Patients with ankylosing spondylitis present a distinct CD8 T cell subset with osteogenic and cytotoxic potential.RMD Open. 2024 Feb 23;10(1):e003926. doi: 10.1136/rmdopen-2023-003926. RMD Open. 2024. PMID: 38395454 Free PMC article.
-
Low-Dose Staphylococcal Enterotoxin C2 Mutant Maintains Bone Homeostasis via Regulating Crosstalk between Bone Formation and Host T-Cell Effector Immunity.Adv Sci (Weinh). 2023 Oct;10(28):e2300989. doi: 10.1002/advs.202300989. Epub 2023 Aug 8. Adv Sci (Weinh). 2023. PMID: 37552005 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources